About Us
- Home
- About Us
PicoImmune Co.
NanoBiotec, LLC (d/b/a, PicoImmune Co.) is a privately held contract research organization (CRO) dedicated to increasing the efficiency of discovering and developing novel therapeutic drugs.
PicoImmune was founded by scientists, is run by scientists, and works for scientists. Our services, designed by our immunologists and cancer biologists, have been sought after by a wide range of scientific institutions from startups to major pharma and biotech companies, along with well-known academic institutions.
Our Vision
To provide ultra-sensitive and reliable bioassay services to monitor real-time changes in genes and proteins from minimal cell culture, animal, and patient samples to accelerate the discovery and development of novel therapeutics.
Our Mission
We provide high-quality and cost-effective services to the biopharma industry and academic investigators to accelerate discovery and development of novel drugs and personalized medicine for cancer, inflammation, and other diseases with unmet needs.
Our mission is to provide maximal insights from a minimal amount of sample and accelerate the translation of high-caliber innovations to therapeutics as efficiently as possible for the benefit of our clients and patients today, rather than in the future.
Our Vision
To provide ultra-sensitive and reliable bioassay services to monitor real-time changes in genes and proteins from minimal cell culture, animal, and patient samples to accelerate the discovery and development of novel therapeutics.
Our Mission
We provide high-quality and cost-effective services to the biopharma industry and academic investigators to accelerate discovery and development of novel drugs and personalized medicine for cancer, inflammation, and other diseases with unmet needs.
Our mission is to provide maximal insights from a minimal amount of sample and accelerate the translation of high-caliber innovations to therapeutics as efficiently as possible for the benefit of our clients and patients today, rather than in the future.